130 related articles for article (PubMed ID: 32972637)
1. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with PGRMC1 expression in breast tumour tissue and with clinical breast tumour characteristics.
Cai G; Yang X; Ruan X; Wang J; Fang Y; Wei Y; Zhang Y; Gu M; Mueck AO
Maturitas; 2020 Oct; 140():64-71. PubMed ID: 32972637
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating Progesterone Receptor Membrane Component-1 (PGRMC1) with breast tumor characteristics and comparison with known tumor markers.
Ruan X; Cai G; Wei Y; Gu M; Zhang Y; Zhao Y; Mueck AO
Menopause; 2020 Feb; 27(2):183-193. PubMed ID: 31876619
[TBL] [Abstract][Full Text] [Related]
3. PGRMC1 in animal breast cancer tissue and blood is associated with increased tumor growth with norethisterone in contrast to progesterone and dydrogesterone: four-arm randomized placebo-controlled xenograft study.
Cai G; Ruan X; Gu M; Zhao Y; Wang Y; Mueck AO
Gynecol Endocrinol; 2020 Nov; 36(11):1024-1027. PubMed ID: 32208774
[TBL] [Abstract][Full Text] [Related]
4. May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer?
Zhang Y; Ruan X; Willibald M; Seeger H; Fehm T; Neubauer H; Mueck AO
Gynecol Endocrinol; 2016; 32(1):58-60. PubMed ID: 26303031
[TBL] [Abstract][Full Text] [Related]
5. Elevated progesterone receptor membrane component 1/sigma-2 receptor levels in lung tumors and plasma from lung cancer patients.
Mir SU; Ahmed IS; Arnold S; Craven RJ
Int J Cancer; 2012 Jul; 131(2):E1-9. PubMed ID: 21918976
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of progesterone receptor membrane component 1 is associated with aggressive phenotype and poor prognosis in ER-positive and negative breast cancer.
Ruan X; Zhang Y; Mueck AO; Willibald M; Seeger H; Fehm T; Brucker S; Neubauer H
Menopause; 2017 Feb; 24(2):203-209. PubMed ID: 27749742
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of novel hormone receptors PGRMC1 and PGRMC2 as potential biomarkers of breast adenocarcinoma staging.
Causey MW; Huston LJ; Harold DM; Charaba CJ; Ippolito DL; Hoffer ZS; Brown TA; Stallings JD
J Surg Res; 2011 Dec; 171(2):615-22. PubMed ID: 20655063
[TBL] [Abstract][Full Text] [Related]
8. [Expression of progesterone receptor membrane component-1 is associated with the malignant phenotypes of breast cancer].
Ji S; Wu A; Yang H
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):635-8. PubMed ID: 22588913
[TBL] [Abstract][Full Text] [Related]
9. High Level of Progesteron Receptor Membrane Component 1 (PGRMC 1) in Tissue of Breast Cancer Patients is Associated with Worse Response to Anthracycline-Based Neoadjuvant Therapy.
Willibald M; Wurster I; Meisner C; Vogel U; Seeger H; Mueck AO; Fehm T; Neubauer H
Horm Metab Res; 2017 Aug; 49(8):595-603. PubMed ID: 28701017
[TBL] [Abstract][Full Text] [Related]
10. PGRMC1: a new biomarker for the estrogen receptor in breast cancer.
Craven RJ
Breast Cancer Res; 2008; 10(6):113. PubMed ID: 19090968
[TBL] [Abstract][Full Text] [Related]
11. Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Tsai HW; Ho CL; Cheng SW; Lin YJ; Chen CC; Cheng PN; Yen CJ; Chang TT; Chiang PM; Chan SH; Ho CH; Chen SH; Wang YW; Chow NH; Lin JC
World J Gastroenterol; 2018 Mar; 24(10):1152-1166. PubMed ID: 29563759
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H; Clare SE; Wozny W; Schwall GP; Poznanovic S; Stegmann W; Vogel U; Sotlar K; Wallwiener D; Kurek R; Fehm T; Cahill MA
Breast Cancer Res; 2008; 10(5):R85. PubMed ID: 18922159
[TBL] [Abstract][Full Text] [Related]
14. Absence of progesterone receptor membrane component 1 reduces migration and metastasis of breast cancer.
Lee SR; Lee YH; Jo SL; Heo JH; Kim G; Lee GS; An BS; Baek IJ; Hong EJ
Cell Commun Signal; 2021 Apr; 19(1):42. PubMed ID: 33832499
[TBL] [Abstract][Full Text] [Related]
15. Expression and significance of ER, PR, VEGF, CA15-3, CA125 and CEA in judging the prognosis of breast cancer.
Zhang SJ; Hu Y; Qian HL; Jiao SC; Liu ZF; Tao HT; Han L
Asian Pac J Cancer Prev; 2013; 14(6):3937-40. PubMed ID: 23886210
[TBL] [Abstract][Full Text] [Related]
16. Serum Tumor Marker Levels might have Little Significance in Evaluating Neoadjuvant Treatment Response in Locally Advanced Breast Cancer.
Wang YJ; Huang XY; Mo M; Li JW; Jia XQ; Shao ZM; Shen ZZ; Wu J; Liu GY
Asian Pac J Cancer Prev; 2015; 16(11):4603-8. PubMed ID: 26107211
[TBL] [Abstract][Full Text] [Related]
17. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
18. Clinical Importance of PGRMC1 in Hormone Responsive Breast Cancer.
Ruan X; Mueck AO
Breast Care (Basel); 2023 Jun; 18(3):172-178. PubMed ID: 37529370
[TBL] [Abstract][Full Text] [Related]
19. The presence of a membrane-bound progesterone receptor induces growth of breast cancer with norethisterone but not with progesterone: A xenograft model.
Zhao Y; Ruan X; Wang H; Li X; Gu M; Wang L; Li Y; Seeger H; Mueck AO
Maturitas; 2017 Aug; 102():26-33. PubMed ID: 28610679
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
